Lexaria Bioscience last closed at $2.77 (-3.82%) on 2026-10-05. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -0.6×. Its overall grade ranks 622 of 741 stocks in Healthcare.
About this company
Lexaria Bioscience last closed at $2.77 (-3.82%) on 2026-10-05. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall D · 622/741
Valuation grade C
Related stocks
- British American TobaccoCustomer
니코틴/흡입 기술 관련 잠재적 제휴·상업화 고객으로 자주 거론됨
- Philip Morris InternationalCustomer
흡연 대체·니코틴 전달 기술의 주요 잠재 고객
- Altria GroupCustomer
니코틴 제품·전자담배 관련 기술 라이선스 잠재 고객
About Lexaria Bioscience
- What technical signals does Lexaria Bioscience (LEXX) have?
- Lexaria Bioscience current technical signals: MACD bullish cross.
- Is Lexaria Bioscience a cup-and-handle pattern?
- No. Lexaria Bioscience has no valid Cup signal right now.
- What published figures are available for Lexaria Bioscience?
- Market cap: $4.6M. Trailing 12 months PER: -0.6×. Latest quarter PBR: 1.05×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about Lexaria Bioscience, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy